“…Among the 23 genes previous studies have shown their correlation with AD, we have: GFAP [ 41 , 42 ], PDGFRβ [ 43 – 45 ], NFKBIA [ 46 ], TNFRSF1B [ 47 ], NOTCH1 [ 48 ], BCL6 [ 49 ], CSF1R [ 50 ], LEP [ 51 ], DCLRE1C [ 52 ], KCNJ10 [ 53 ], MAP2K1 [ 54 ], VIP [ 55 ], SNCA [ 56 ], ENO2 [ 57 ], SST [ 58 ], UCHL1 [ 59 ], HPRT1 [ 60 ], STAT4 [ 61 ], CD14 [ 62 ], ITGB2 [ 63 ], SPP1 [ 64 ], STX1A [ 65 ], and SYP [ 66 ]. And these genes are involved in the regulation of molecules associated with the complement system, for instance, GFAP [ 67 ], PDGFRβ [ 68 ], NFKBIA [ 69 ], TNFRSF1B [ 70 ], NOTCH1 [ 71 ], BCL6 [ 72 ], CSF1R [ 73 ], LEP [ 74 ], DCLRE1C [ 75 ], KCNJ10 [ 76 ], MAP2K1 [ 77 ], VIP [ 78 ], SNCA [ 79 ], ENO2 [ 80 ], SST [ 81 ], UCHL1 [ 82 ], HPRT1 [ 83 ], STAT4 [ 84 ], CD14 [ 85 ], ITGB2 [ 86 ], SPP1 [ 87 ], STX1A [ 88 ], and SYP [ 89 ]. However, few studies have discussed their role in AD pathology by modulating the complement system, our study may be a new perspective for our future exploration of the relationship between AD and the complement system.…”